corporate headquarters
Allergan, Inc.
2525 Dupont Drive
P.O. Box 19534
Irvine, CA 92623-9534
(714) 246-4500
E-mail: corpinfo@allergan.com
Internet: www.allergan.com
transfer agent, registrar and dividend disbursing agent, duplicate mailings
Wells Fargo Shareowner Services
P.O. Box 64854
St. Paul, MN 55164-0854
(800) 468-9716
Hearing Impaired # TDD: (651) 450-4144
Internet: www.wellsfargo.com/shareownerservices
annual meeting of stockholders
The Annual Meeting of Stockholders of Allergan, Inc. will be held at The Irvine Marriott Hotel, 18000 Von Karman Avenue, Irvine, CA 92612, on May 2, 2006, at 10:00 a.m. Pacific Standard Time.
market prices of common stock and dividends
The following table shows the quarterly price range of the common stock and the cash dividends declared per share during the period listed.
 | | | |||||||||
| 2005 | | 2004 | ||||||||
| |||||||||||
| Calendar Quarter | High | Low | Div | High | Low | Div | |||||
| |||||||||||
| First | $81.16 | $69.60 | $.10 | $90.21 | $75.65 | $.09 | |||||
| Second | 86.29 | 69.01 | .10 | 92.61 | 83.13 | .09 | |||||
| Third | 95.43 | 83.36 | .10 | 90.36 | 69.05 | .09 | |||||
| Fourth | 110.50 | 85.90 | .10 | 82.10 | 66.78 | .09 | |||||
| | | | | |||||||
Allergan common stock is listed on the New York Stock Exchange and is traded under the symbol “AGN.” In newspapers, stock information is frequently listed as “Alergn.” The approximate number of stockholders of record was 5,900 as of February 8, 2006.
form 10-k
A copy of Allergan, Inc.’s Annual Report on Form 10-K, as filed with the Securities and Exchange Commission, is available through our Web site at www.allergan.com or without charge by contacting:
investor relations
James M. Hindman
Allergan, Inc.
P.O. Box 19534
Irvine, CA 92623-9534
Phone: (714) 246-4636 Fax: (714) 246-4800
E-mail: corpinfo@allergan.com
dividend reinvestment and stock purchase plan
The plan allows Allergan stockholders to reinvest their dividends or invest cash in Allergan stock without brokerage commissions or service charges. If you are interested in joining the plan or would like more information, you may request a prospectus from:
Wells Fargo Shareowner Services
Dividend Reinvestment Plan/Allergan, Inc.
P.O. Box 64856
St. Paul, MN 55164-0856
trademarks
Except as set forth below, all product names appearing in capital letters are trademarks or service marks that are owned by, licensed to, or promoted by Allergan, Inc., its subsidiaries or affiliates. The following Allergan trademarks appear in this report: ALOCRIL, ALPHAGAN, ALPHAGAN P, AVAGE, AZELEX, BIB, BIODIMENSIONAL, BIOENTERICS, BOTOX, BOTOX Cosmetic, CELLUFRESH, CELLUVISC, COMBIGAN, COSMODERM, COSMOPLAST, ELESTAT, EXOCIN, FLUOROPLEX, HYDRAFILL, LACRI-LUBE, LAP-BAND, LIQUIFILM, LUMIGAN, M.D. FORTE, OCUFLOX, OFLOX, POSURDEX, PRED FORTE, PREVAGE MD, REFRESH, REFRESH CONTACTS, REFRESH DRY EYE THERAPY, REFRESH ENDURA, REFRESH LIQUIGEL, REFRESH PLUS, REFRESH P.M., REFRESH TEARS, RELESTAT, RELIEF, RESTASIS, TAZORAC, TAZORAL, VISTABEL, VISTABEX, ZORAC, ZYDERM, ZYMAR and ZYPLAST.
ACULAR and ACULAR LS are registered trademarks of Roche Palo Alto LLC.
AMERGE and IMITREX STATdose System are registered trademarks of Glaxo Group Limited.
CAPTIQUE and HYLAFORM are registered trademarks of Genzyme Corporation.
JUVÉDERM is a registered trademark of Laboratoires d’Esthetique Appliquee.
RESTYLANE is a registered trademark of Ha North American Sales AB.
VIAGRA is a registered trademark of Pfizer, Inc.